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CONSIDERABLE interest has been aroused
in recent years by the possibility of using
liposomes for the delivery of cytotoxic
drugs. By altering the distribution of the
drug between tissues, liposomes may
protect against systemic toxicity, and the
attachment of ligands to the liposome
surface (Szoka & Papahadjopoulos, 1981)
may enable targeting to specific types
of cell (Huang et al., 1980; Mauk et al.,
1980).
A major drawback to the liposomal
delivery of water-soluble drugs, such as
daunorubicin, methotrexate and cytosine
arabinoside, is that during preparation of
liposomes only a small.proportion of the
drug may become encapsulated, and sub-
sequent retention is highly dependent on
the integrity of the liposomal membranes
(Stamp & Juliano, 1979). One solution
to this problem is to modify the compound
by the addition of lipophilic side-chains,
so that it partitions into the lipid rather
than into the aqueous phase (Knight,
1981). We have synthesized some N-acyl
derivatives of daunorubicin and measured
their retention within dimyristoylphos-
phatidylcholine (DMPC) liposomes. We
report below the toxicity of these
liposomes to L929 cells in culture.
Daunorubicin-HCl was kindly given by
Farmitalia, Milan, Italy. N-Acyl dauno-
rubicin derivatives with acyl chain lengths
of 2, 4, 8 and 16 carbon atoms were made
by the mixed-anhydride method (Albert-
son, 1962) and purified by preparative
thin-layer chromatography on silica gel.
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[14C]-Labelled Cg and C16 derivatives were
made by the same method, by using
[1-14C]octanoic or [1-14C]palmitic acid
(Radiochemical Centre, Amersham,
Bucks). Phospholipids were purchased
from Sigma London Chemical Co. (Poole,
Dorset). Cells and materials for cell
culture were from Flow Laboratories
(Irvine, Ayrshire).
DMPC liposomes, containing up to
10 mol% N-acyl daunorubicin and 5
mol% dipalmitoylphosphatidic acid
(DPPA) were prepared by hydrating the
constituents ( 5 mg total lipid) freeze-
dried from t-butanol, at 370C with 5 ml
of serum-free Dulbecco's minimum essen-
tial medium, fortified with the non-essen-
tial amino acids (DMEM). Liposomes were
annealed at 37°C for at least 1 h, washed
twice by centrifugation at 200 g, and
resuspended in DMEM containing 10%
(v/v) newborn calf serum. Liposomes
prepared in this way were used for drug-
retention and cytotoxicity studies.
Both N-acetyl and N-butyryl dauno-
rubicin were poorly incorporated into
liposomes, and their retention and cyto-
toxicity were not investigated further.
The incorporation of the N-octanoyl
(DRO) and N-palmitoyl (DRP) com-
pounds was measured by using N-[14C]-
acyl daunorubicins (10 mol %) in lipo-
somes trace-labelled with di-[3H]-palmi-
toylphosphatidylcholine (Shaw et al.,
1979). Centrifugation of these liposomes
at 2000 g precipitated more than 80% of
both 3H and 14C radioactivities, and thereD. R. BARD, C. G. KNIGHT AND D. P. PAGE-THOMAS
was no significant difference between the
14C/3H ratios in the pellet and super-
natant. Retention of DRO and DRP by
these liposomes after resuspension in
DMEM containing 10% newborn calf
serum, was measured by incubating them
in roller tubes for up to 5 days, and
centrifuging at 100,000 g at 24 h inter-
vals. Both compounds remained associ-
ated with the lipid, though with the DRO
liposomes there was a 27% increase in the
14C/3H ratio in the supernatant (P < 0 02)
between Days 3 and 5, implying some
loss of DRO from the liposomes. 14C/3H
ratios in the supernatant from the DRP
liposomes remained constant.
Cytotoxicity was measured in subcon-
fluent coverslip cultures (22 mm square)
of the murine areolar-tissue-derived cell
line L929 (Sandford et al., 1948) by
incubating the cells ( 5 x 105) with the
N-acyldaunorubicin liposomes, freedauno-
rubicin, a daunorubicin-DNA complex or
drug-free liposomes, at 37°C in an atmo-
sphere of 5% CO2 in air for 3 days. Cell
death was assessed by trypan-blue ex-
clusion (Paul, 1972) by the cells in situ
and was expressed as the percentage with
nuclear staining. At least 400 cells per
culture were counted, and not less than
5 cultures were used at each drug con-
centration. Statistical significance of the
differences between groups of replicate
cultures was assessed by the t test
(double sided, variances not assumed
equal) after converting the percentage
results to arcsines.
Dose-response curves (Figure) obtained
by diluting a liposome suspension initially
containing 800 ,uM DMPC, 95 ,uM N-
acyl daunorubicin and 45 ,uM DPPA,
revealed that DRO was more cytotoxic
than DRP in the concentration range 5
to 95utM (P < 0-01) though both deriva-
tives were less active than free daunorubi-
cin (P < 0 01). However, when the DMPC
concentration was kept constant at 800,uM
and the dose of DRO was decreased by
lowering the proportion of the drug in the
liposomes, there was a marked enhance-
ment of cytotoxicity at the lower con-
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FIGURE.-Toxicity of daunorubicins to L929
cells after 72h incubations. (0) N-octanoyl
daunorubicin in liposomes; (E0) N-palmi-
toyl daunorubicin in liposomes; (A) dauno-
rubicin-HCl; (V) daunorubicin-DNA.
( ~) Concentration changed by dilu-
tion; (----) experiments at constant lipid
concentration. (See text for details.)
centration (Figure). Indeed, DMPC lipo-
somes (800,uM) containing 0'8 ,uM DRO
were more cytotoxic than free dauno-
rubicin at the same concentration.
Microscopic examination of L929 cells
incubated with DRO liposomes showed
an intense orange fluorescence that ap-
peared initially to be located principally
in the cytoplasm, but spread to the
nucleus as the incubation proceeded.
Cells incubated with DRP liposomes
showed a similar staining pattern, though
nuclear fluorescence appeared rather later.
Cells incubated with daunorubicin or
daunorubicin-DNA showed strong nuclear
fluorescence after 2 h, and little or no
cytoplasmic fluorescence at any stage.
We have found that 10mol% of N-
acyl daunorubicin can be incorporated
efficiently into DMPC liposomes, pro-
vided that the N-acyl substituent is 8
or more carbon atoms long. Both DRO and
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DRP remained associated with the lipo-
somes during incubation for 5 days in
culture medium containing 10% newborn
calf-serum.
Dose-response curves (Figure) showed
that liposomes containing 10 mol % N-
acyl daunorubicins were less cytotoxic to
L929 cells than free daunorubicin. This
difference appeared to be due to N-
substitution, as found by Aszalos et al.
(1979) with another cell line, since the
toxicity of the analogues was related to
the lengths of the N-acyl chain, and could
not be accounted for by differences in
incorporation or retention by liposomes.
Furthermore, the toxicity of liposomal
N-acyl daunorubicins to L929 cells was
highly dependent on lipid concentration,
confirming that their action was mediated
by the liposomes, though the mechanisms
involved were not investigated.
The mode of action of N-acyl dauno-
rubicins is not entirely clear, and may
differ from that of the unmodified com-
pound (Aszalos et al., 1979). Free dauno-
rubicin can interact with the DNA
double helix and block transcription
(Ward et al., 1965) but N-acyl dauno-
rubicins do not interact specifically with
DNA (Aszalos et al., 1979; Di Marco &
Arcamone, 1975). Daunorubicin can also
act by inhibiting respiration (Murphree
et al., 1976) and by generating superoxide
radicals (Bozzi et al., 1981) and these
mechanisms of cytotoxicity would pre-
dominate in the case of analogues unable
to bind to DNA. Our observations that
N-acyl daunorubicins or their metabolites
can eventually enter the nucleus, and
that DRO, which accumulates in the
nucleus more rapidly, is the more toxic,
suggest that these compounds may be
metabolized in L929 cells to derivatives
which can bind to DNA and act in a,
manner analogous to the parent
compound.
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